Literature DB >> 8363209

Weight loss and subsequent death in a cohort of U.S. adults.

E R Pamuk1, D F Williamson, M K Serdula, J Madans, T E Byers.   

Abstract

OBJECTIVE: Because we previously found that weight loss was associated with increased risk for death in all but very overweight men in a cohort of U.S. adults, we undertook a new analysis to determine whether inadequate control for preexisting illness or cigarette smoking contributed to this association.
DESIGN: Cohort study.
SETTING: The first National Health and Nutrition Examination Survey (NHANES I, 1971 to 1975) collected information on maximum lifetime weight and measured current weight on a probability sample of U.S. adults. The NHANES I Epidemiologic Follow-up Study determined the vital status of participants through 1987. PARTICIPANTS: Men (n = 2453) and women (n = 2739) who were 45 to 74 years old at the time of the NHANES I examination.
RESULTS: The effect of excluding persons who died within the first 5 and first 8 years after baseline was examined to limit the influence of weight loss due to preexisting illness. For women, extension of the exclusionary period weakened the association between weight loss and increased risk for death from noncardiovascular disease. However, excluding death for as much as 8 years after baseline did not affect the strong association between weight loss and increased risk for death from cardiovascular disease among men and women with maximum body mass indexes between 26 and 29 (relative risks of up to 2.1 and 3.6 for men and women, respectively, after excluding deaths in the first 8 years). Results were not substantially altered by limiting the analysis to persons who never smoked.
CONCLUSIONS: Preexisting illness may influence the association between weight loss and death principally through deaths from noncardiovascular disease. For some persons, weight loss is associated with an increased risk for death, even after excluding deaths occurring in the first 8 years.

Entities:  

Mesh:

Year:  1993        PMID: 8363209     DOI: 10.7326/0003-4819-119-7_part_2-199310011-00023

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

Review 1.  [What should be done in weight loss of unknown origin?].

Authors:  A Schwenk
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 3.  Weight loss in older adults.

Authors:  David R Thomas
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

4.  Implications of Look AHEAD for clinical trials and clinical practice.

Authors:  R R Wing
Journal:  Diabetes Obes Metab       Date:  2014-06-22       Impact factor: 6.577

Review 5.  Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-07-15       Impact factor: 8.262

6.  Aging, Obesity, and Mortality: Misplaced Concern About Obese Older People?

Authors:  Roland J Thorpe; Kenneth F Ferraro
Journal:  Res Aging       Date:  2004-01-01

7.  Determining the Nutritional Status of the Elderly in post-cold war Russia.

Authors:  M J Toole; M Serdula
Journal:  Am J Public Health       Date:  1996-03       Impact factor: 9.308

Review 8.  Surgical intervention as a strategy for treatment of obesity.

Authors:  L Sjöström
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.633

Review 9.  All-Cause and Cause-Specific Mortality Associated with Bariatric Surgery: A Review.

Authors:  Ted D Adams; Tapan S Mehta; Lance E Davidson; Steven C Hunt
Journal:  Curr Atheroscler Rep       Date:  2015-12       Impact factor: 5.113

Review 10.  Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-05-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.